141 related articles for article (PubMed ID: 9808575)
41. Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.
Robledo MM; Sanz-Rodriguez F; Hidalgo A; Teixidó J
J Biol Chem; 1998 May; 273(20):12056-60. PubMed ID: 9575147
[TBL] [Abstract][Full Text] [Related]
42. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Garrido SM; Appelbaum FR; Willman CL; Banker DE
Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
[TBL] [Abstract][Full Text] [Related]
43. Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1994 May; 18(5):337-46. PubMed ID: 8182924
[TBL] [Abstract][Full Text] [Related]
44. Induced rearrangement of kappa genes in the BLIN-1 human pre-B cell line correlates with germline J-C kappa and V kappa transcription.
Martin D; Huang RQ; LeBien T; Van Ness B
J Exp Med; 1991 Mar; 173(3):639-45. PubMed ID: 1900078
[TBL] [Abstract][Full Text] [Related]
45. Heterotypic adherence between human B-lymphoblastic and pre-B-lymphoblastic cells and marrow stromal cells is a biphasic event: integrin very late antigen-4 alpha mediates only the early phase of the heterotypic adhesion.
Patrick CW; Juneja HS; Lee S; Schmalstieg FC; McIntire LV
Blood; 1995 Jan; 85(1):168-78. PubMed ID: 7528565
[TBL] [Abstract][Full Text] [Related]
46. Establishment of a leukemic cell model for studying human pre-B to B cell differentiation.
Wörmann B; Anderson JM; Liberty JA; Gajl-Peczalska K; Brunning RD; Silberman TL; Arthur DC; LeBien TW
J Immunol; 1989 Jan; 142(1):110-7. PubMed ID: 2642502
[TBL] [Abstract][Full Text] [Related]
47. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
48. Molecular interactions between human B-cell progenitors and the bone marrow microenvironment.
Murti KG; Brown PS; Kumagai Ma; Campana D
Exp Cell Res; 1996 Jul; 226(1):47-58. PubMed ID: 8660938
[TBL] [Abstract][Full Text] [Related]
49. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
50. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.
Roldán E; García-Pardo A; Brieva JA
J Exp Med; 1992 Jun; 175(6):1739-47. PubMed ID: 1588291
[TBL] [Abstract][Full Text] [Related]
51. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
[TBL] [Abstract][Full Text] [Related]
52. Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.
Wang L; O'Leary H; Fortney J; Gibson LF
Blood; 2007 Nov; 110(9):3334-44. PubMed ID: 17638851
[TBL] [Abstract][Full Text] [Related]
53. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
Furuichi Y; Goi K; Inukai T; Sato H; Nemoto A; Takahashi K; Akahane K; Hirose K; Honna H; Kuroda I; Zhang X; Kagami K; Hayashi Y; Harigaya K; Nakazawa S; Sugita K
Cancer Res; 2007 Oct; 67(20):9852-61. PubMed ID: 17942916
[TBL] [Abstract][Full Text] [Related]
54. Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1994 Jan; 18(1):37-48. PubMed ID: 8289465
[TBL] [Abstract][Full Text] [Related]
55. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.
Manabe A; Coustan-Smith E; Behm FG; Raimondi SC; Campana D
Blood; 1992 May; 79(9):2370-7. PubMed ID: 1373973
[TBL] [Abstract][Full Text] [Related]
57. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.
Mraz M; Zent CS; Church AK; Jelinek DF; Wu X; Pospisilova S; Ansell SM; Novak AJ; Kay NE; Witzig TE; Nowakowski GS
Br J Haematol; 2011 Oct; 155(1):53-64. PubMed ID: 21749361
[TBL] [Abstract][Full Text] [Related]
58. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells.
Saito M; Kumagai M; Okazaki T; Nakazawa S; Shapiro LH; Look AT; Campana D
Leukemia; 1995 Sep; 9(9):1508-16. PubMed ID: 7658720
[TBL] [Abstract][Full Text] [Related]
59. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
[TBL] [Abstract][Full Text] [Related]
60. Establishment of a human pro-B cell line (JKB-1) and its differentiation of preestablished bone marrow stromal cell layer.
Urashima M; Hasegawa N; Kamijo M; Shishikura A; Kato Y; Hoshi Y; Akatsuka J; Maekawa K
Am J Hematol; 1994 Jun; 46(2):112-9. PubMed ID: 8172177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
